** Vitrafy Life Sciences VFY.AX trading flat at A$1.6
** Bell Potter raises PT by 10 Au cents to A$2.10; retains "speculative buy"
** Expects higher cash flows on visibility of commercial launch timing of its VCU2 cryopreservation device in FY26
** Views recent leadership changes positively
** Ord Minnett assigns "speculative buy", with PT of A$2.30, per data compiled by LSEG
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))